Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.
Sarkaria
Jann N
JN
Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA. sarkaria.jann@mayo.edu
Galanis
Eva
E
Wu
Wenting
W
Dietz
Allan B
AB
Kaufmann
Timothy J
TJ
Gustafson
Michael P
MP
Brown
Paul D
PD
Uhm
Joon H
JH
Rao
Ravi D
RD
Doyle
Laurence
L
Giannini
Caterina
C
Jaeckle
Kurt A
KA
Buckner
Jan C
JC